in view of the now officially 700.000 Corona-Infected in India the country gets access to an affordable copycat drug, the whole world has been waiting for: The pharmaceutical manufacturer Mylan will offer Remdesivir for only 4800 rupees (57,23 euros) per 100 milligrams. In America, the dose of the original manufacturer Gilead costs insured 520 dollars (462,12 Euro) for private. The Indian pharmaceutical authority, the DCGI has approved the Mylan-copycat product under the name of Desrem for the subcontinent. It’s supposed to come with “Corona-emergency” use. In this case, should there be severe cases of Corona in adults or children, the scale was the artificial respiration.
Christoph Hein
Economics correspondent for South Asia/Pacific, based in Singapore.
F. A. Z.
The Ministry of health in New Delhi, has reduced the treatment time from six to five days down. A total of 600 milligrams of the drug should be used. This treatment should cost in India to the equivalent of 360 euros, while the price in America will amount to almost 2800 Euro. For the vast majority of the nearly 1.4 billion people, the Western prices for medicines outside each reach.
Since the insurance is developed on the subcontinent completely under, only cheap prices compared to the West: economic power per capita in purchasing power parities in Germany at 55.300 dollars, it is in India only 9027 dollars. Gilead has signed voluntary licence agreements in India, Pakistan and Egypt with the manufacturers Cipla, Dr. Reddy’s Laboratories, Eva Pharma, Ferozsons Laboratories, Hetero Labs, Jubilant Life Sciences, Mylan, Syngeneic, and Zydus Cadila Healthcare. You should distribute the drug in 127 countries. Cipla intends to bring Ciprema in India for less than 5000 rupees to the market, Hetero Labs has awarded its Coviflor 5400 rupees.
America hoarding the drug
In the past few days, it came to a debate Remdesivir and its manufacturer, Gilead, because the United States backed up with a good 500,000 doses practically the entire output for the coming months. American scientists pointed out that it is probably the world’s the first case in which a drug is initially only in a single country exclusive will be sold. India, but with an indentation in the meantime, on place three of the world’s worst of Corona-affected countries. The European Union had approved Remdesivir for heavy corona cases on Friday.
